harmAla Biotech receives guidance on new MDMA-like drug for PTSD and Autism
The MHRA has confirmed that PharmAla’s MDMA-like drug candidate ALA-002 does not require additional preclinical data
https://mugglehead.com/pharmala-biotech-receives-guidance-on-new-mdma-like-drug-for-ptsd-and-autism/
Ann: Psychedelic joint venture with PharmAla Biotech, page-12
Add VIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.4¢ |
Change
-0.004(4.08%) |
Mkt cap ! $54.70M | |||
| Open | High | Low | Value | Volume |
| 9.7¢ | 9.7¢ | 9.4¢ | $24.81K | 259.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 36900 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 22327 | 2 |
View Market Depth
| Last trade - 11.18am 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.3¢ |
Change
-0.004 ( 4.12 %) |
||||
| Open | High | Low | Volume | ||
| 9.7¢ | 9.7¢ | 9.3¢ | 43350 | ||
| Last updated 11.18am 13/05/2024 ? | |||||
| VIT (ASX) Chart |